Cargando…
IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
Lymphoma-associated hemophagocytic syndrome (LAHS) is a serious disorder, and its early diagnosis and treatment with appropriate chemotherapy are very important. However, reliable markers for early diagnosis of LAHS have not been identified. We screened serum cytokines using a newly introduced assay...
Autores principales: | Maruoka, Hayato, Inoue, Daichi, Takiuchi, Yoko, Nagano, Seiji, Arima, Hiroshi, Tabata, Sumie, Matsushita, Akiko, Ishikawa, Takayuki, Oita, Tatsuo, Takahashi, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918116/ https://www.ncbi.nlm.nih.gov/pubmed/23975214 http://dx.doi.org/10.1007/s00277-013-1878-y |
Ejemplares similares
-
Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
por: Rabquer, Bradley J, et al.
Publicado: (2011) -
MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis
por: Tworek, Damian, et al.
Publicado: (2013) -
SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10
por: Sharma, Sherven, et al.
Publicado: (2003) -
An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis
por: Yates-Binder, Cecelia C., et al.
Publicado: (2012) -
The chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia
por: Branch, Donald R., et al.
Publicado: (2022)